CRNX Archived Articles
Crinetics Pharmaceuticals (CRNX): Transforming the Endocrine Landscape with a Robust Pipeline and Promising Commercialization Efforts
Published on March 13, 2025
Crinetics Pharmaceuticals (CRNX): A Diversified Pipeline Poised for Endocrine Breakthroughs
Published on November 02, 2024
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - A Promising Endocrine-Focused Pharmaceutical Company
Published on September 24, 2024